The english version of the website is under development. Wherever text appears in Greek, it means it has not been translated yet.

Δημοσίευση

(99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma.

Title(99m)Tc sestamibi as a prognostic factor of response to first-line therapy and outcome in patients with malignant lymphoma.
Publication TypeJournal Article
Year of Publication2013
AuthorsSpyridonidis, T. J., Matsouka P., Symeonidis A., Savvopoulos C., Vassilakos P. J., & Apostolopoulos D. J.
JournalClin Nucl Med
Volume38
Issue11
Pagination847-54
Date Published2013 Nov
ISSN1536-0229
KeywordsAdolescent, Adult, Aged, Aged, 80 and over, Disease Progression, Female, Humans, Kaplan-Meier Estimate, Lymphoma, Male, Middle Aged, Prognosis, Proportional Hazards Models, ROC Curve, Technetium Tc 99m Sestamibi, Treatment Outcome, Young Adult
Abstract

INTRODUCTION: Resistance to chemotherapy poses a major problem in cancer patients. Although of multifactorial origin, some of the implicated mechanisms also interfere with (99m)Tc-MIBI uptake and retention in cancer cells. The aim of the current study was to investigate the prognostic value of baseline (99m)Tc-MIBI imaging in lymphoma.METHODS: (99m)Tc-MIBI SPECT was performed in 16 patients with Hodgkin lymphoma and 31 with non-Hodgkin lymphoma (NHL) before chemotherapy initiation. Early (20 minutes), late (120 minutes) tumor-to-background (T/B) ratios, and 2-hour (99m)Tc-MIBI washout were calculated. Follow-up data were obtained for a period of 45.5 ± 23.5 months. Study end points were response to first-line chemotherapy, lymphoma-related death (LRD), and time to disease progression.RESULTS: Of the scintigraphic indices examined, the late T/B ratio correlated best with study end points. A cutoff value of 1.8 determined by receiver operating characteristic analysis discriminated poor from good response and LRD from survival with an accuracy of 87% and 81%, respectively. Kaplan-Meier survivor functions separated by this cutoff differed significantly for both time to disease progression and LRD (P = 0.0001 and P = 0.0015). In the Cox proportional hazards model, the late T/B ratio proved to have an independent and incremental value over clinical prognostic factors (age, lymphoma type, Ann Arbor stage, lactate dehydrogenase levels) and, in NHL patients, over the international prognostic index. Patients with high international prognostic index score could be further stratified into different prognostic categories.CONCLUSION: The current study indicates that baseline (99m)Tc-MIBI SPECT can provide useful prognostic information in patients with lymphoma, particularly NHL, regarding therapy response and final outcome.

DOI10.1097/RLU.0b013e3182a755c8
Alternate JournalClin Nucl Med
PubMed ID24089060

Contact

Secretariat of the School of Medicine
 

Connect

School of Medicine's presence in social networks
Follow Us or Connect with us.